
Led by Prof @Jamie_Rossjohn FRS we are focused on understanding molecular bases underpinning protective and aberrant immunity
Monash University, Australia
Joined July 2014
- Tweets4.7K
- Following666
- Followers1.5K
- Likes4.6K
Rossjohn lab retweeted
🚨🧬An in vivo cell therapy engineering platform of transformative potential. Congratulations to @j_eyquem and team on a breathtaking (and groundbreaking) body of work. @parkerici @UCSF
nature.com/articles/s41586-0…
Rossjohn lab retweeted
NHMRC Investigator Grants out today.
A devastating day for many. I have already received messages from some of the best researchers I know who have missed out.
The senior levels had a cutoff of 5.93 (females), 6.2 (males) - according to my sources.
The impact will be wide spread.
The damage being done at the moment to the sector is totally unacceptable. We need to do a lot more to support our research community.
Rossjohn lab retweeted
#StarsOfScience – Professor Jane Visvader's groundbreaking discoveries at @WEHI_research have fundamentally changed how we understand breast development and cancer.
Prof Jane Visvader – Ruby Payne-Scott Medal and Lecture 2025
Working at WEHI, Jane’s breast stem cell discoveries reshaped cancer science, revealing BRCA1 cancer origins and sparking a global prevention trial for high-risk women.
Congrats to PhD student, Liam Rashleigh, whose 1st authored paper on gd T cell receptor recognition was published today @Structure_CP
cell.com/structure/fulltext/…
#GDTcellclub @MonashUni @RossjohnLab
Rossjohn lab retweeted
Early bird registration pricing for CD1-MR1 2025 ends this Friday, 6th June! Get on it 👉👉 cd1mr1.com
Rossjohn lab retweeted
Congrats to Hien, 1st author of this study that arose from her hard work during her PhD.
Latest research from @jbiolchem “The molecular basis of T cell receptor recognition of citrullinated tenascin-C presented by HLA-DR4” by Dao et al. jbc.org/article/S0021-9258(2… @ASBMB @Jamie_Rossjohn
Rossjohn lab retweeted
In collaboration with Moody lab, latest paper from @RossjohnLab describing the structure of a lipopeptide bound to a MHC-I like molecule found in chickens - hopefully this study will not ruffle too many feathers.
Rossjohn lab retweeted
Your immune system gradually loses it top team players when we get older 👱➡️👵
Our study in @eBioMedicine investigates how long our good immune cells stay around – a 🧵⬇️ go.unimelb.edu.au/4sep
@CvandeSandt @KatherineKedz @TheDohertyInst #Influenza #AgingResearch
Rossjohn lab retweeted
Our latest paper demonstrating the potential of “our” DOT cells against colorectal cancer has just been published in @NatureCancer:
rdcu.be/ehYwG
Many congrats to the whole team, especially @RafaelBlancoDom! :)
Rossjohn lab retweeted
Recent paper from lab describing a peptide-independent MHC-restricted T cell receptor nature.com/articles/s41467-0… in collaboration with La Gruta lab @MonashUni @Monash_FMNHS @RossjohnLab @NatureComms
In collaboration with @NicoleLaGruta1 and colleagues, latest paper from @Jamie_Rossjohn lab describing role of Lck-coreceptor assocation in T cell function. @MonashUni
science.org/doi/10.1126/scii…
Rossjohn lab retweeted
Researchers in Science #Immunology have identified CD8+ T cells from human donors that can recognize naturally occurring influenza variants spanning more than 100 years, including the 1918 influenza A and 2024 #H5N1. @Jamie_Rossjohn @kedzierskalab
scim.ag/4hpSzh1
Rossjohn lab retweeted
🚨 Flu breakthrough! 🚨 Researchers at @TheDohertyInst & @MonashUni have discovered immune cells that recognise flu viruses even as they mutate—a further step toward a universal flu vaccine. go.unimelb.edu.au/d7z8 @UniMelbMDHS @TheRMH @oanheei @Jamie_Rossjohn @kedzierskalab @KatherineKedz
Rossjohn lab retweeted
Our latest study @SciImmunology identifies the molecular determinants of cross-reactive B35/NP418-restricted CD8+ T cells across IAVs from 1918 H1N1 to 2024 H5N1, and assesses their functionality.
@KatherineKedz @RossjohnLab
science.org/doi/10.1126/scii…
Rossjohn lab retweeted
TCR-peptide-HLA ternary structures define molecular mechanisms of TCR cross-reactivity toward natural influenza variants @SciImmunology
science.org/doi/10.1126/scii…
@RossjohnLab @Jamie_Rossjohn @kedzierskalab @KatherineKedz
Rossjohn lab retweeted
science.org/doi/10.1126/scii… First paper from the @JohnstoneLab for the year and a brilliant collaboration with @TheDohertyInst colleagues Dan Utzschneider and Alex Kallies. Thanks to all @PeterMacRes @PeterMacCC for help and support and great job Dane Newman and Leonie Cluse!
Rossjohn lab retweeted
Ziggy enjoying park time #roughcollie
Rossjohn lab retweeted
Researchers paid $8.968 billion for their findings to be freely accessible.
🧵1/10
Rossjohn lab retweeted
Fast and accurate modeling of TCR-peptide-MHC complexes using tFold-TCR
1. tFold-TCR introduces a high-throughput, end-to-end method for predicting TCR-peptide-MHC (TCR-pMHC) complex structures, overcoming challenges in TCR-pMHC interactions and enabling rapid and precise 3D structure modeling.
2. The model leverages a specially trained protein language model (PLM) that extracts intra- and inter-chain residue contact information, eliminating the need for laborious multiple sequence alignment (MSA) searches and achieving remarkable speed improvements.
3. Compared to existing methods like AlphaFold-3, tFold-TCR shows a 30.7% increase in prediction accuracy, achieving fast and reliable results in seconds, significantly enhancing computational efficiency.
4. The tFold-TCR model was used to construct TCRStructDB, the largest database of TCR-pMHC structures, including 2.2 million TCRs, 0.8 million pMHCs, and 45,000 TCR-pMHC complexes, providing unprecedented insights into immune system interactions.
5. With the ability to predict unliganded TCRs, unbound pMHCs, and complex TCR-pMHC structures, tFold-TCR advances our understanding of the immune system, supporting cancer immunotherapy and improving vaccine development.
6. Despite superior performance on TCRs and MHC-I interactions, the model's prediction of MHC-II complexes lags behind AlphaFold-3, indicating challenges due to the structural complexities of MHC-II molecules.
7. The platform allows large-scale structural predictions, offering a robust tool for drug discovery, vaccine design, and personalized immunotherapies, and is available via the online TCRStructDB database.
8. tFold-TCR sets a new standard in modeling TCR-pMHC complexes, providing a critical resource for advancing immunological research and therapeutic strategies.
@Jamie_Rossjohn @RossjohnLab @supercs08 @aaguaijie
💻Code: github.com/TencentAI4S/tfold
📜Paper: biorxiv.org/content/10.1101/…
#Immunotherapy #TCRModeling #CancerResearch #Bioinformatics #MachineLearning
























